Trial Profile
A Phase 2 Study Of UCN-01 In Advanced Renal Cell Carcinoma
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 24 Dec 2009
Price :
$35
*
At a glance
- Drugs UCN 01 (Primary)
- Indications Renal cancer
- Focus Therapeutic Use
- 01 Sep 2006 Status change
- 11 Sep 2005 New trial record.